Publicacions en col·laboració amb investigadors/es de Hospital General Universitario de Alicante (46)

2024

  1. Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome

    Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1

  2. Use of multi-gene panels in patients at high risk of hereditary digestive cancer: position statement of AEG, SEOM, AEGH and IMPaCT-GENÓMICA consortium

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 293-318

2023

  1. Microglia activation and neuronal alterations in retinas from COVID-19 patients: correlation with clinical parameters

    Eye and Vision, Vol. 10, Núm. 1

2022

  1. Lynch-like Syndrome: Potential Mechanisms and Management

    Cancers, Vol. 14, Núm. 5

2021

  1. Clyta-daao chimeric enzyme bound to magnetic nanoparticles. A new therapeutical approach for cancer patients?

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-24

2020

  1. CLyta-DAAO, free and immobilized in magnetic nanoparticles, induces cell death in human cancer cells

    Biomolecules, Vol. 10, Núm. 2

  2. Cell death mechanisms induced by CLytA‐DAAO chimeric enzyme in human tumor cell lines

    International Journal of Molecular Sciences, Vol. 21, Núm. 22, pp. 1-25

  3. Clinical and Pathological Characterization of Lynch-Like Syndrome

    Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 2, pp. 368-374.e1

  4. Differential effects of IGF-1R small molecule tyrosine kinase inhibitors BMS-754807 and OSI-906 on human cancer cell lines

    Cancers, Vol. 12, Núm. 12, pp. 1-18

  5. Hereditary leiomyomatosis and renal cell cancer syndrome in spain: Clinical and genetic characterization

    Cancers, Vol. 12, Núm. 11, pp. 1-16

  6. Risk of cancer in family members of patients with lynch-like syndrome

    Cancers, Vol. 12, Núm. 8, pp. 1-12

2019

  1. DNA Methylation of tumor suppressor genes in pituitary neuroendocrine tumors

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 4, pp. 1272-1282

  2. Radiotherapy resistance acquisition in glioblastoma. Role of SOCS1 and SOCS3

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Characterization of a novel POLD1 missense founder mutation in a Spanish population

    Journal of Gene Medicine, Vol. 19, Núm. 4

  2. Evaluation of the Sepsis Flow Chip assay for the diagnosis of blood infections

    PLoS ONE, Vol. 12, Núm. 5

  3. Performance of a quantitative pcrbased assay and beta-D-glucan detection for diagnosis of invasive candidiasis in very-low-birth-weight preterm neonatal patients (candineo study)

    Journal of Clinical Microbiology, Vol. 55, Núm. 9, pp. 2752-2764

  4. Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors

    PLoS ONE, Vol. 12, Núm. 3

2016

  1. Bicytopenia due to parvovirus b19 infection in octogenarian: a case report

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 29, Núm. 2, pp. 105-106

2015

  1. Serological study of Trypanosoma cruzi, Strongyloides stercoralis, HIV, human T cell lymphotropic virus (HTLV) and syphilis infections in asymptomatic Latin-American immigrants in Spain

    Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol. 109, Núm. 7, pp. 447-453